Nerre Therapeutics Holdings Limited STEVENAGE


Nerre Therapeutics Holdings Limited is a private limited company located at Stevenage Bioscience Catalyst, Incubator Building, Gunnels Wood Road, Stevenage SG1 2FX. Incorporated on 2017-05-03, this 6-year-old company is run by 7 directors.
Director Javier G., appointed on 25 June 2021. Director Andrew K., appointed on 15 September 2017. Director Iain D., appointed on 08 September 2017.
The company is classified as "research and experimental development on biotechnology" (Standard Industrial Classification code: 72110).
The latest confirmation statement was filed on 2023-06-25 and the date for the subsequent filing is 2024-07-09. Furthermore, the annual accounts were filed on 30 June 2022 and the next filing is due on 31 March 2024.

Nerre Therapeutics Holdings Limited Address / Contact

Office Address Stevenage Bioscience Catalyst, Incubator Building
Office Address2 Gunnels Wood Road
Town Stevenage
Post code SG1 2FX
Country of origin United Kingdom

Company Information / Profile

Registration Number 10753026
Date of Incorporation Wed, 3rd May 2017
Industry Research and experimental development on biotechnology
End of financial Year 30th June
Company age 7 years old
Account next due date Sun, 31st Mar 2024 (27 days after)
Account last made up date Thu, 30th Jun 2022
Next confirmation statement due date Tue, 9th Jul 2024 (2024-07-09)
Last confirmation statement dated Sun, 25th Jun 2023

Company staff

Javier G.

Position: Director

Appointed: 25 June 2021

Andrew K.

Position: Director

Appointed: 15 September 2017

Iain D.

Position: Director

Appointed: 08 September 2017

Mary K.

Position: Director

Appointed: 08 September 2017

Geert M.

Position: Director

Appointed: 08 September 2017

Ena P.

Position: Director

Appointed: 08 September 2017

Saiyed M.

Position: Director

Appointed: 08 September 2017

Michael T.

Position: Director

Appointed: 03 May 2017

Resigned: 08 September 2017

People with significant control

The list of persons with significant control who own or control the company is made up of 2 names. As we identified, there is Advent Life Sciences Llp from London, England. This PSC is categorised as "a limited liability partnership", has 25-50% voting rights and has 25-50% shares. This PSC has 25-50% voting rights and has 25-50% shares. The second one in the persons with significant control register is Michael T. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.

Advent Life Sciences Llp

158-160 North Gower Street, London, NW1 2ND, England

Legal authority Limited Liabilities Partnership Act 2000
Legal form Limited Liability Partnership
Country registered England
Place registered England
Registration number Oc347034
Notified on 8 September 2017
Ceased on 25 June 2021
Nature of control: 25-50% voting rights
25-50% shares

Michael T.

Notified on 3 May 2017
Ceased on 8 September 2017
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Company filings

Filing category
Accounts Capital Confirmation statement Incorporation Insolvency Officers Persons with significant control Resolution
Statement of Capital on 5th September 2023: 3630.89 GBP
filed on: 13th, September 2023
Free Download (4 pages)

Company search

Advertisements